Petros Pharmaceuticals annual gross profit
2020
2021
2022
2023
2024
2025
Petros Pharmaceuticals Gross Profit Growth & History (PTPI)
Petros Pharmaceuticals's gross profit was $0 for fiscal 2025.
View full Petros Pharmaceuticals company overviewPetros Pharmaceuticals annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $0 | −$3.9M | — |
| 2024 | 2024-12-31 | $3.9M | −$291,825 | −6.96% |
| 2023 | 2023-12-31 | $4.2M | $488,532 | +13.19% |
| 2022 | 2022-12-31 | $3.7M | −$2.5M | −40.39% |
| 2021 | 2021-12-31 | $6.2M | $698,695 | +12.67% |
| 2020 | 2020-12-31 | $5.5M | — | — |
Petros Pharmaceuticals quarterly gross profit
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Gross profit | Change | YoY change |
|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | $460,646 | $983,044 | — |
| Q3 2024 | 2024-09-30 | $1.3M | $23,179 | +1.83% |
| Q2 2024 | 2024-06-30 | $1.1M | −$387,793 | −26.20% |
| Q1 2024 | 2024-03-31 | $1.1M | −$910,255 | −46.27% |
| Q4 2023 | 2023-12-31 | −$522,398 | −$439,166 | — |
| Q3 2023 | 2023-09-30 | $1.3M | $3.0M | — |
| Q2 2023 | 2023-06-30 | $1.5M | −$2.1M | −58.16% |
| Q1 2023 | 2023-03-31 | $2.0M | −$25,599 | −1.28% |
| Q4 2022 | 2022-12-31 | −$83,232 | $1.0M | — |
| Q3 2022 | 2022-09-30 | −$1.7M | −$3.6M | — |
| Q2 2022 | 2022-06-30 | $3.5M | $1.5M | +71.35% |
| Q1 2022 | 2022-03-31 | $2.0M | −$1.4M | −41.94% |
| Q4 2021 | 2021-12-31 | −$1.1M | −$2.3M | — |
| Q3 2021 | 2021-09-30 | $1.8M | −$656,781 | −26.45% |
| Q2 2021 | 2021-06-30 | $2.1M | $1.2M | +147.43% |
| Q1 2021 | 2021-03-31 | $3.4M | $2.4M | +240.54% |
| Q4 2020 | 2020-12-31 | $1.2M | — | — |
| Q3 2020 | 2020-09-30 | $2.5M | — | — |
| Q2 2020 | 2020-06-30 | $834,333 | — | — |
| Q1 2020 | 2020-03-31 | $1.0M | — | — |
Petros Pharmaceuticals gross profit trends
Over the last five fiscal years, Petros Pharmaceuticals's gross profit decreased from $5.5M to $0, a change of −$5.5M. The latest reported quarter, Q4 2024, shows $460,646.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Petros Pharmaceuticals source filings ↗